Marijuana Retail Report

After holding a Dec. 10 meeting with cannabis industry leaders in the Oval Office, Trump is expected to issue an executive order directing top officials in his cabinet to reclassify the plant to a less restrictive status under the Controlled Substances Act (CSA). The Washington Post reported on Thursday.

Health Secretary Robert F. Kennedy Jr. and Centers for Disease Control and Prevention Mehmet Oz also attended the meeting, while the president called U.S. House Speaker Mike Johnson, D-La Licia, who opposed the plan, arguing that some studies and data do not support the move, according to media reports.

According to the current Schedule I, which the federal government ranks along with heroin, LSD, and ecstasy among the drugs with the highest potential for abuse, the federal government does not recognize marijuana as currently recognized for medical use in the United States. That will change under the White House’s expected plan to relocate the plant; however, the president cannot unilaterally move cannabis, and he has not made a final decision.

To read the rest of this article on Cannabis Business Times, Click here